In October 2024, a new paper on the topic of conjugated NOD2/TLR7 agonists entitled: Linker Chemistry and Connectivity Fine-Tune the Immune Response and Kinetic Solubility of Conjugated NOD2/TLR7 Agonists (https://pubs.acs.org/doi/10.1021/acs.bioconjchem.4c00321) was published in Bioconjugate Chemistry by our very own Špela Janež as part of her ongoing PhD research.
Congrats, Špela!
